Vitamin D and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
Abstract Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was ask...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-07-01
|
| Series: | EFSA Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.2903/j.efsa.2015.4182 |
| _version_ | 1819135291288453120 |
|---|---|
| author | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
| author_facet | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
| author_sort | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
| collection | DOAJ |
| description | Abstract Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to vitamin D and its contribution to the normal function of the immune system. The Panel considers that vitamin D is sufficiently characterised. A contribution to the normal function of the immune system is a beneficial physiological effect. The Panel has previously assessed claims on vitamin D and its contribution to the normal function of the immune system with favourable outcomes. The target populations were the general population and children aged 3 to 18 years. The Panel considers that the role of vitamin D in the functioning of the immune system applies to all ages, including infants and young children (from birth to three years of age). The Panel concludes that a cause and effect relationship has been established between the dietary intake of vitamin D and contribution to the normal function of the immune system. The following wording reflects the scientific evidence: ‘Vitamin D contributes to the normal function of the immune system.’ The target population is infants and young children up to three years of age. |
| first_indexed | 2024-12-22T10:16:45Z |
| format | Article |
| id | doaj.art-8b4725dab83f47b2b633289acf4d339d |
| institution | Directory Open Access Journal |
| issn | 1831-4732 |
| language | English |
| last_indexed | 2024-12-22T10:16:45Z |
| publishDate | 2015-07-01 |
| publisher | Wiley |
| record_format | Article |
| series | EFSA Journal |
| spelling | doaj.art-8b4725dab83f47b2b633289acf4d339d2022-12-21T18:29:43ZengWileyEFSA Journal1831-47322015-07-01137n/an/a10.2903/j.efsa.2015.4182Vitamin D and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)Abstract Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to vitamin D and its contribution to the normal function of the immune system. The Panel considers that vitamin D is sufficiently characterised. A contribution to the normal function of the immune system is a beneficial physiological effect. The Panel has previously assessed claims on vitamin D and its contribution to the normal function of the immune system with favourable outcomes. The target populations were the general population and children aged 3 to 18 years. The Panel considers that the role of vitamin D in the functioning of the immune system applies to all ages, including infants and young children (from birth to three years of age). The Panel concludes that a cause and effect relationship has been established between the dietary intake of vitamin D and contribution to the normal function of the immune system. The following wording reflects the scientific evidence: ‘Vitamin D contributes to the normal function of the immune system.’ The target population is infants and young children up to three years of age.https://doi.org/10.2903/j.efsa.2015.4182vitamin Dinfantschildrenimmune systemhealth claims |
| spellingShingle | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Vitamin D and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 EFSA Journal vitamin D infants children immune system health claims |
| title | Vitamin D and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_full | Vitamin D and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_fullStr | Vitamin D and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_full_unstemmed | Vitamin D and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_short | Vitamin D and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_sort | vitamin d and contribution to the normal function of the immune system evaluation of a health claim pursuant to article 14 of regulation ec no 1924 2006 |
| topic | vitamin D infants children immune system health claims |
| url | https://doi.org/10.2903/j.efsa.2015.4182 |
| work_keys_str_mv | AT efsapanelondieteticproductsnutritionandallergiesnda vitamindandcontributiontothenormalfunctionoftheimmunesystemevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 |